Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

01 Jun 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has attached a media release on 1st June 2021 titled ‘Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg ‘which is self?explanatory.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..